Glimepiride 1 mg + Metformin 500 mg + Pioglitazone 15 mg Tablet (Glucim-P1)
Glimepiride 1 + Metformin 500 + Pioglitazone 15 mg — Triple OAD
| Composition | Glimepiride 1 mg + Metformin 500 mg + Pioglitazone 15 mg |
|---|---|
| Dosage Form | Tablet |
| Pack Type | Box |
| Pack Size | 20 x 15 (Blister) |
| MRP | ₹ 2200 |
| Therapy | Cardiac + Diabetic — Sulphonylurea + biguanide + thiazolidinedione (Triple OAD) |
| Storage | Store below 25°C. |
WhatsApp EnquiryCall: +919041677932
For chemists, distributors and doctors: Glucim-P1 (glimepiride 1 mg + metformin 500 mg + pioglitazone 15 mg tablet) is available from Trumac Healthcare on a PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000 – work out your margin with the PTR / PTS calculator.
Buying this composition for PCD franchise, wholesale or under your own brand? See Glimepiride 1 mg + Metformin 500 mg + Pioglitazone 15 mg Tablet – manufacturer, supplier & PCD franchise for available packs and brand options.
See the full antidiabetic tablets range – manufacturer, supplier and PCD franchise: SGLT2 and DPP-4 inhibitors, glimepiride, gliclazide, metformin, voglibose and their combinations.
Schedule G: Metformin is listed in Schedule G of the Drugs Rules, 1945, so the pack carries the red-box caution “SCHEDULE G PRESCRIPTION DRUG – CAUTION: It is dangerous to take this preparation except under medical supervision”. Combinations that also contain a Schedule H molecule carry the Rx label too. See the Schedule G drugs list.
About Glucim-P1 SR Tablet
Glucim-P1 SR Tablet combines three complementary oral antidiabetic agents: Glimepiride 1 mg (sulphonylurea — stimulates insulin secretion), Metformin 500 mg (biguanide — reduces hepatic glucose output) and Pioglitazone 15 mg (thiazolidinedione — improves peripheral insulin sensitivity).
The triple combination is indicated for type-2 diabetes patients with significant insulin resistance who fail dual oral therapy and need glycaemic intensification before insulin.
Camrut Healthcare manufactures Glucim-P1 under WHO-GMP conditions for PCD pharma franchise across India.
Glucim-P1 का उपयोग (हिंदी में): टाइप 2 डायबिटीज़ (शुगर) की दवा। सभी Trumac दवाओं के उपयोग हिंदी और अंग्रेज़ी में – Trumac Healthcare tablet uses A–Z। दवा हमेशा डॉक्टर की सलाह से ही लें।
Indications
- Type-2 DM uncontrolled on dual OAD
- Significant insulin resistance
- Glycaemic step-up prior to insulin initiation
Mechanism of Action
Glimepiride closes pancreatic beta-cell ATP-sensitive K+ channels, triggering insulin secretion. Metformin activates AMPK, suppressing hepatic gluconeogenesis and improving peripheral glucose utilisation. Pioglitazone is a PPAR-gamma agonist that increases insulin-sensitive gene expression in adipose and muscle tissue.
Dosage & Administration
- Adults: 1 tablet once daily before breakfast
- Swallow whole
- Monitor liver enzymes and fluid status
- Use under physician supervision
Side Effects
- Hypoglycaemia (sulphonylurea)
- GI upset (metformin)
- Weight gain and fluid retention (pioglitazone)
- Anaemia
- Macular oedema (rare)
Contraindications & Precautions
- Type-1 diabetes
- NYHA Class III–IV heart failure
- Active bladder cancer
- Severe renal or hepatic impairment
- Pregnancy and breastfeeding
Storage
Store below 25°C.
From Trumac Healthcare, a pharma franchise company in India, available on a monopoly basis – see the cardiac-diabetic products franchise product list (PDF). See our full PCD franchise tablets range. Comparing companies? See the compare cardiac diabetic PCD companies. No franchise fee; minimum first order ₹25,000 – cost and documents.
Glucim-P1 SR Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
q
a
q
a
q
a
q
a
q
a
Related Products
- Glucim-M3 Forte SR Tablet — Metformin HCl 1000 mg + Glimepiride 3 mg
- Glibicam-Forte Tablet — Glibenclamide 5 mg + Metformin 500 mg + Pioglitazone 15 mg
